Georgia Medical Cannabis Enrollment Surges Following Major Expansion of Patient Access

Georgia Medical Cannabis Enrollment Surges After 2026 Law Change

Georgia’s medical cannabis program is experiencing a dramatic increase in participation following one of the most significant cannabis policy reforms in the state’s history.

More than 8,000 additional patients have joined Georgia’s Medical Cannabis Patient Registry since lawmakers approved an expansion of the program in May 2026. The increase represents growth of more than 20%, bringing statewide enrollment to nearly 45,000 registered patients.

The enrollment spike offers a clear lesson for policymakers in Georgia, Florida and across the country: When states build medical cannabis programs that respond to patients’ actual needs, more people are willing and able to participate.

Georgia’s Putting Patients First Act Expands Medical Cannabis Access

Senate Bill 220, officially known as the Putting Georgia’s Patients First Act, took effect on July 1, 2026.

Before the change, Georgia operated an unusually restrictive program that primarily permitted registered patients to access low-THC oil. The limited selection of products and narrow eligibility requirements prevented many patients from finding appropriate relief through the state-regulated system.

SB 220 modernized that framework by permitting qualified patients to access additional medical cannabis products, including botanical cannabis intended for vaporization by registered adults aged 21 and older.

The law also replaced Georgia’s former 5% THC concentration limit with a possession standard based on total THC content. Registered patients and caregivers may now legally possess regulated medical cannabis products containing a combined total of up to 12,000 milligrams of THC, according to the Georgia Department of Public Health.

Individual packages may contain no more than 1,200 milligrams of THC.

More Medical Conditions Now Qualify

The new Georgia medical cannabis law also expands the number of patients eligible to participate.

Inflammatory bowel disease and lupus are now included among the state’s qualifying conditions. Lawmakers also relaxed severity requirements previously imposed on patients with multiple sclerosis, Parkinson’s disease and certain other diagnoses.

Georgia currently recognizes 18 qualifying medical conditions, including:

• Cancer

• Epilepsy and other qualifying seizure disorders

• Multiple sclerosis

• Parkinson’s disease

• Inflammatory bowel disease

• Intractable pain

• Post-traumatic stress disorder

• Lupus

• Sickle cell disease

• Alzheimer’s disease

• Severe peripheral neuropathy

• Autism spectrum disorder under qualifying circumstances

Patients must receive certification from a fully licensed Georgia physician whose principal practice is located in the state. An active registry card is required to legally purchase and possess products through Georgia’s regulated medical cannabis system.

Why Enrollment Increased So Quickly

The addition of more than 8,000 patients in a relatively short period suggests that Georgia’s previous restrictions were suppressing participation.

Patients do not benefit from a medical cannabis program simply because it exists on paper. A functional program must include reasonable eligibility standards, useful formulations, adequate potency and practical access to regulated products.

Georgia’s reforms addressed several of those barriers simultaneously. The state expanded the qualifying-condition list, increased the types of products available and replaced the restrictive THC percentage cap with a more flexible possession limit.

The result was immediate: Thousands of residents entered the regulated program once it became more relevant to their medical needs.

Following the passage of SB 220, National NORML began classifying Georgia as the 41st state with an effective medical cannabis law.

What Georgia’s Law Still Prohibits

Georgia’s reform represents meaningful progress, but it is not adult-use legalization.

Cannabis possession by individuals who are not registered patients or caregivers remains illegal under state law. Registered patients also remain subject to significant limitations.

Georgia still prohibits:

• Smoking medical cannabis

• Personal home cultivation

• Unlicensed sales

• Recreational possession or purchases

• Cannabis-infused candies and cookies

Patients may purchase approved, laboratory-tested products only through licensed medical cannabis dispensaries or qualifying independent pharmacies. Authorized products include oils, tinctures, capsules, lotions, transdermal patches, ingestible formulations and vaporization products.

Medical cannabis must remain in its original pharmaceutical container, and its label must identify the product’s THC content.

A Relevant Lesson for Florida Lawmakers

Georgia’s enrollment growth should be closely watched by policymakers throughout the South, including here in Florida.

When lawmakers remove arbitrary restrictions and allow physicians and patients greater flexibility, participation in regulated medical cannabis programs grows. That growth does not necessarily represent an increase in illness or cannabis use. It may instead reflect patients moving away from an inadequate or unregulated system and into a safer, tested and legally protected market.

Florida has a considerably larger medical cannabis program, but patients in the Sunshine State still confront restrictions involving employment protections, housing, criminal justice, federal law and personal cultivation.

Georgia’s experience demonstrates that cannabis reform is not merely a theoretical political issue. Legislative language determines whether real patients can obtain products that work for them without risking arrest or being forced into an illicit market.

The Bottom Line

Georgia’s medical cannabis registry grew by more than 20% after lawmakers expanded eligibility and permitted patients to access a broader range of products. Nearly 45,000 Georgians are now registered, including more than 8,000 who joined following the passage of SB 220.

The rapid increase provides compelling evidence that patients respond when medical cannabis laws become more practical, inclusive and focused on healthcare rather than stigma.

Georgia’s program remains restrictive in several important respects, but the Putting Georgia’s Patients First Act represents substantial progress—and its early enrollment numbers show just how much demand existed for meaningful medical cannabis access.

This article is based on original reporting published by National NORML. Suncoast NORML credits National NORML for the original story and encourages readers to review it here: “Georgia: Enrollment in State’s Medical Cannabis Access Program Spikes Following Law Change.”